To provide managed care and community pharmacists with up-to-date information regarding their role in managing patients with fibromyalgia.
This activity is designed for managed care and community pharmacists. No prerequisites required.
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. At the conclusion of this activity, the participant should be able to:
- Describe the current diagnostic criteria and neuroimaging diagnostic techniques supporting the evidence of central sensitization, as well as genetic polymorphisms.
- Explain how dysregulation of the hypothalamic-pituitary-adrenal axis increases neurotransmitter response to pain in patients with fibromyalgia syndrome (FMS).
- Compare and contrast the pharmacokinetics and the efficacy and safety of targeted neurotransmitter therapies and alternative medical therapies used to treat FMS.
- Identify healthcare barriers encountered when managing medications for patients with FMS and develop strategies to increase quality of patient care.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing pharmacy education for pharmacists.
CREDIT DESIGNATION STATEMENT
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based educational activity will provide a statement for 2.0 contact hours credit (0.2 CEUs) and will be available for download following successful completion of the activity. Successful completion includes participating in the activity, completing a self-assessment instrument with a score of at least 70%, and completing an evaluation instrument. If you score less than 70% on the self-assessment instrument, you will be allowed to complete the examination one more time. ACPE Program # 064-000-09-209-H01-P.
This continuing pharmacy education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.
The estimated time to complete this educational activity: 2 hours.
Release date: October 15, 2009. Expiration date: October 15, 2011.
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of The University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an activity sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
This activity is supported by an educational grant from Pfizer Inc